About Immunic (IMUX)
Immunic, Inc., formerly Vital Therapies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases. The Company is developing three small... Read more
- USD1.25
- USD1.32
- USD1.18
- USD3.11
- -3.10%
- --
- 367.20k
- 273.52k
- 130M
- 0.95
- -21.60%
Stock News
3 hours ago
Apple Has Been Left Behind in the AI Rally. Why It Might One Day Still Be the Big Winner.
Yahoo
yesterday
Cramer’s week ahead: Earnings from Tesla, Merck and Big Tech
CNBC
yesterday
TV and film jobs may never fully recover post-pandemic, strikes, says Teamsters president
CNBC
yesterday
KKR Real Estate Finance Trust Inc. Declares Preferred Stock Dividend
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
